Karyopharm Therapeutics (KPTI) Enters $50M Controlled Equity Offering Sales Agreement
Tweet Send to a Friend
Karyopharm Therapeutics (NASDAQ: KPTI) disclosed the following on Tuesday:On December 7, 2015, Karyopharm Therapeutics Inc. (the “Company”) entered into a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
